Acceptance of invitations for p53 and BRCA1 predisposition testing: Factors infleuencing potential utilization of cancer genetic testing cancer genetic testing

Psycho-Oncology

Volumn 5, Issue 3, 1996, Pages 241-250

  Patenaude, Andrea Farkas ^a   Schneider, Katherine A ^b   Kieffer, Stephanie A ^b   Calzone, Kathleen A ^b   Stopfer, Jill E ^b   Basili, Laura A ^b   Weber, Barbara L ^b   Garber, Judy E ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER SCREENING; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; FAMILIAL CANCER; FEMALE; HUMAN; MALE; MEDICAL PSYCHOLOGY; ONCOGENE;

EID: 10144246571     PISSN: 10579249     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1099-1611(199609)5:3<241::aid-pon235>3.3.co;2-y     Document Type: Article

References (38)

1. Beck A. T., and Steer, R. A. (1987) Beck Depression Inventory Manual. The Psychological Corporation, San Antonio TX.
2. Beck, A. T. and Steer, R. A. (1988) Beck Hopelessness Scale Manual. Psychological Corporation, San Antonio, TX.
3. Becker, M. H. (ed.) (1974) The Health Belief Model and personal health behavior. 2Health Educ. Nonogr. 2, 45-50, 1974.
4. Brugieres, L., Gardes, M., Moutou, C., Chompret, A, Meresse, V., Martin, A., Poisson, N., Flamant, F., Bonaiti-Pellie, C. and Lemerle, J. (1993) Screening for germ line p53 mutations in children with malignant tumors and a family history of cancer. Cancer Research 53, 452-455.
5. Burger, J. M. and Cooper, H. M. (1979) The desirability of control, Motivation and Emotion 3, 381-393.
6. Codor, A. M., Hanson, R. and Brandt, J. (1994) Self-selection in predictive testing for Huntington's disease. Am. J. Med. Genet. 54, 167-173.
7. Derogatis, L. R. (1983) SCL-90 Administration, Scoring, and Procedures Manual. Clinical Psychometric Research, Towson MD.
8. Derogatis, L. R. and Spencer, P. M. (1992) Brief Symptom Inventory (BSI): Administration, Scoring and Procedures Manual. Clinical Psychometric Research, Baltimore.
9. Evers-Kieboom, C., Swerts, A., Cassiman, J. J. and Van Den Berghe, H. (1989) The motivation of at-risk individuals and their partners in deciding for or against predictive testing for Huntington's disease. Clin. Genetics 35, 29-40.
10. Ford, D., Easton, D. F. Bishop, D. T., Narod, S. A., Goldgar, D. E. and Breast Cancer Linkage Consortium (1994) Risks of cancer in BRCA1-mutation carriers. Lancet 343, 692-695.
11. Jacopini, G. A., D'Amico, R., Frontali, J. J. and Vivona, G. (1992) Attitudes of persons at risk and their partners toward predictive testing. Birth Defects :Original Articles Series 28, 113-117.
12. Kash, K. M., Holland, J. C., Halper, M. S. and Miller, D. G. (1992) Psychological distress behaviors of women with a strong family history of breast cancer. J. Natl. Ca. Inst. 84, 24-30.
13. Kerner, J. Cancer Anxiety and Helpless. Unpublished measure. Adapted by Kash in Kash, K. M., Holland, J. C., Halpern, M. S. and Miller, D. G. Psychological distress behaviors of women with a strong family history of breast cancer (1992), J. Natl. Ca. Inst. 84, 24-30.
14. Kessler, J. S. (1994) Predictive testing for Huntington disease: A psychologist's view. Am. J. Med. Genet. 54, 161-166.
15. Lerman, C., Daly, M., Masny, A. and Balshem, A. (1994) Attitudes about genetic testing for breast-ovarian cancer susceptibility. J. Clin. One. 12, 843-850.
16. Lerman, C., Seay, J., Balshem, A and Audrain, J. (1995) Interest in genetic testing among first-degree relatives of breast cancer patients. Am. J. Med. Genet. 57, 385-392.
17. Lerman, C., Trock, B., Rimer, B. K., Boyce, A., Jepson, C. and Engstrom, P. F. (1991) Psychological and behavioral implications of abnormal mammograms. Ann. Int. Med. 114, 657-661.
18. Li, F. P., Correa, P. and Fraumeni, J. F. Jr. (1991) Testing for germ line p53 mutations in cancer families. Cancer Epid, Biomarkers, and Prev. 1, 91-94.
19. Lynch, H. T., Watson, P., Conway., T. A., Lynch, J. F., Slominski-Caster, S. M., Narol, S. A., Feuteun, J. and Lenoir, G. 1993 DNA screening for breast/ ovarian cancer susceptibility based on linked markers. Arch. Intern. Med. 153, 1979-1987.
20. Mastromauri, C., Myers, R. H. and Berkman, B. (1987) Attitudes 3 towards presymptomatic testing in Huntington disease. Am. J. Med. Genet. 26, 271-282.
21. Miller, S. M. (1987) Monitoring and blunting: Validation of a questionnaire to assess styles of information seeking under threat, J. Pers. Soc. Psych. 52, 345-353.
22. Quaid, K. A. (1992) Presymptomatic testing for Huntington's disease: The U.S. experience. Am. J. Hum. Genet. 51, 1063.
23. Quaid, K. A. (1993) Presymptomatic testing for Huntington disease in the United States. Am. J. Hum. Genet. 53, 785-787.
24. Quaid, K. A. and Morris, M. (1993) Reluctance to undergo predictive testing: The case of Huntington disease. Am. J. Med. Genet. 45, 41-45.
25. Rosenberg, M. 1965 Society and the Adolescent Self-Image. Princeton G University Press, Princeton NJ.
26. Sarason, I. G., Sarason, B. R., Shearin, E. N. and Pierce, G. R. (1987) A brief measure of social support: Practical and theoretical implications, J. Soc. and Pers. Relationships 4, 497-510.
27. Steele, G. D., Jr., Jessup, L. M., Winchester, D. P., Murphy, G. P., and Menck, H. R. (1995) Clinical highlights from the National Cancer data base: 1995. CA 45, 102-111.
28. Tambor, E. S., Bernhardt, B. A., Chase, G. A., Faden, R. R., Geller G., Hofman, K. J. and Holtzman, N. A. (1994) Offering cystic fibrosis screening to an HMO population: factors associated with utilization. Am. J. Hum. Genet. 55, 626-637.
29. Elizabeth Thompson, Acting Director of the Ethical, Legal, and Social Implications program of the U.S. Human Genome Project, personal communication, October 1995.
30. Tobin, D. L. (1984) User's Manual for the Coping Strategies Inventory. Baystate Medical Center, Springfield MA.
31. Tyler, A., Ball, D. and Craufurd, D. (1992) Presymptomatic testing for Huntington's disease in the United Kingdom. Br. Med. J. 304, 1593-1596.
32. Tyler, A. and Harper, P. S. (1983) Attitudes of subjects at risk and their relatives toward genetic counselling in Huntington's chorea. J. Med. Genet. 20, 179-188.
33. van der Steenstraten, I. M., Tibben, A., Roos, R. A. C., van de Kamp, J. J. P. and Niermeijer, M. F. (1994) Predictive testing for Huntington disease: Nonparticipants compared with participants in the Dutch program. Am. J. Hum. Genet. 55, 618-625.
34. Vogel, V. G., Graves, D. S., Vernon, S. W., Lord, J. A., Winn, R. J. and Peters, G. N. (1990) Mammographic screening of women with increased risk of breast cancer. Cancer 66, 1613-1620.
35. Wallston, K. A. and Wallston B. S. (1978) Development of the Multidimensional Health Locus of Control (MHLC) Scales. Health Education Monographs 6, 161-171.
36. Wandle, J. and Pope, R. (1992) The psychological costs of screening for cancer. J. Psychosom. Res. 36, 609-624.
37. Williams, W. R. and Strong, L. C. (1985) Genetic epidemiology of soft tissue sarcomas in children, in Familial Cancer (H. Mueller and W. Weber Eds) S. Karger, Basel, Switzerland.
38. Wolff, G. and Walter, W. (1992) Attitudes of at-risk persons for Huntington disease toward predictive testing. Birth Defects: Original Articles Series 28, 119-126.